CXCL11 and cancer: In fact, it was proposed that TRIP-Br3 negatively regulates tumorigenesis by inhibiting the expression of JUN oncogene, while TRIP-Br1, TRIP-Br2, and SERTAD3 positively affect it in multiple human cancers [9, 12, 21, 23–28].